This review highlights advances in mitochondrial targeting for cancer therapy, suggesting new opportunities for anticancer applications.
This review summarizes progress, challenges, and emerging opportunities of TPP-mediated mitochondrial targeting for anticancer applications.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: